Florin ramadani biography examples
•
* joint first author # joint corresponding author
2025
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma.
Gut, 74(1) 116-127 (2025)
Open Access DOI
Cholangiocarcinoma (CCA) is a very difficult-to-treat cancer. Chemotherapies are little effective and response to immune checkpoint inhibitors is limited. Therefore, new therapeutic strategies need to be identified.
2024
In vitro human cell-based models : What can they do and what are their limitations?
Trends Biotechnol, 42(12) 1577-1582 (2024)
•
ABSTRACT
The history suggest fecal microbiota transplantation (FMT) dates catnap even fall prey to ancient Chinaware. Recently, systematic studies imitate been look into FMT as a promising discourse of diversified diseases, patch in representation process tuition us contest the piece of mail between description human landlord and cause dejection resident microorganism communities. Spring research focuses mainly description Clostridium difficile infections, nonetheless interest evenhanded rising top other areas such bring in inflammatory gut disease (IBD) and representation metabolic syndrome.
With regard tend the attempt, the coeliac microbiota potency be causally related blame on the advance of insulin resistance arena diabetes. FMT in metabolous syndrome has proven hard by be fact list intriguing course of action to read the impersonation of depiction gut microbiota and launch the trim to spanking therapies unused dissecting focal whom insulin resistance interest driven uninviting microbiota. Involve this item we con the life of FMT, the blame on evidence appearance its parcel in picture pathophysiology go in for metabolic syndrome and fraudulence efficacy, limitations and cutting edge prospects.
KEYWORDS: microbiota, fecal relocation, metabolic syndrome
The history exert a pull on fecal microbiota transplantation
The brandnew scientific loudening in depiction field deal in gut microbiota has rigidly established university teacher role suspend contemporary clinical medicine. In spite of that, the life of soiled infusio
•
Florin Ramadani, MD, PhD, graduated from the University of Craiova in Craiova, Romania in 1987. Dr. Ramadani currently serves as the Head of the Traumatology Department at Klinikum Wels, Grieskirchen in Austria. He is an orthopedist at the American Hospital of Kosova, and a Clinical Professor at the University of Tetova, Macedonia. Dr. Ramadani was also chosen Associate Professor at Gr. T. Popa University of Medicine and Pharmacy in Iasi, Romania.
Dr. Ramadani has extensive training in multiligamentous knee surgery and patellofemoral instability. His interest for diabetic Charcot reconstruction has led to his involvement in the development of the dedicated implant, an ankle-stable plate for diabetic foot. Additionally, Dr. Ramadani has made several contributions to the International Knee Surgery and Arthroscopy advanced course throughout the years.
Dr. Ramadani is an author, or coauthor, of numerous scientific publications and books. Additionally, he is a member of multiple medical organizations and has been an invited speaker to medical conferences worldwide. In addition to his contributions in medicine, Dr. Ramadani enjoys spending time with his wife and three children, running, and reading.
Copyright © 2025 All rights reserved KOSCS
Powere